Literature DB >> 3203185

Decreased oesophageal blood flow in patients with Raynaud's phenomenon.

J J Belch1, D Land, R H Park, J H McKillop, J F MacKenzie.   

Abstract

Cold-induced vasospasm seen in systemic sclerosis (SS) and Raynaud's phenomenon (RP) has previously been thought to be limited to peripheral skin sites. However, the oesophageal problems seen in SS cannot be sufficiently explained by connective tissue damage/abnormal motility alone. We wondered if temperature dependent ischaemia could occur in the oesophageal microcirculation. We have measured oesophageal temperature variation following oesophageal cold challenge: 50 ml of water at 7 degrees C and 17 degrees C, with 37 degrees C used as control, were introduced into the mid-oesophagus at a rate of 2 ml/s. Temperature was recorded using a thermocouple probe 5 cm above the gastro-oesophageal junction. The test was performed on 14 SS patients, eight patients with Raynaud's disease and 21 controls. The control's rewarming pattern followed a simple exponential curve. This did not vary with temperature or after repeated challenge. In the SS patients the time constant was significantly longer after cold challenge.

Entities:  

Mesh:

Year:  1988        PMID: 3203185     DOI: 10.1093/rheumatology/27.6.426

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  5 in total

1.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

2.  Large vessel disease in CREST.

Authors:  J J Belch; D J Veale; T Colleridge
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

3.  Antimyenteric neuronal antibodies in scleroderma.

Authors:  S Howe; E Y Eaker; J E Sallustio; C Peebles; E M Tan; R C Williams
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 4.  Pharmacotherapy of Raynaud's phenomenon.

Authors:  J J Belch; M Ho
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

5.  A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

Authors:  C G P Roberts; L K Hummers; W J Ravich; F M Wigley; G M Hutchins
Journal:  Gut       Date:  2006-03-09       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.